Laurel Bernstein

VP, Intellectual Property at OmniAb, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US
Languages
  • English -
  • French -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Registered Patent Agent
    USPTO

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • VP, Intellectual Property
      • Nov 2022 - Present

    • Director Of Intellectual Property
      • Apr 2018 - Nov 2022

    • Exec. Director of Intellectual Property
      • Dec 2006 - Dec 2016

      Sole in-house patent practitioner responsible for drafting over 50 US patent applications and for prosecuting all patent applications (a docket of over 150 pending and issued patents), managing academic and corporate partner collaborations; reviewing publications and presentations to safeguard proprietary information; handling material transfer agreements. Provided input and guidance to management team for portfolio management. Practice areas include antibody technology, core antibody production platform for generating antibodies to small bioactive lipids; reagents and kits; treatment methods; clinical and pre-clinical drug development compounds.

    • United States
    • Biotechnology Research
    • 500 - 600 Employee
    • Executive Director of Patents
      • 1991 - 2005

      Responsible for the antisense biology docket as Isis’ portfolio grew to over 1200 issued patents (over 650 in US) and approximately 1600 pending cases. Practice includes antisense to numerous gene targets, core antisense/RNA technologies, clinical drug development compounds (including areas of metabolics, cancer and inflammation), and other technologies. Experience includes extensive patent drafting experience, as well as oversight of patent prosecution (US and foreign) for a large docket. Responsible for the antisense biology docket as Isis’ portfolio grew to over 1200 issued patents (over 650 in US) and approximately 1600 pending cases. Practice includes antisense to numerous gene targets, core antisense/RNA technologies, clinical drug development compounds (including areas of metabolics, cancer and inflammation), and other technologies. Experience includes extensive patent drafting experience, as well as oversight of patent prosecution (US and foreign) for a large docket.

    • Postdoctoral Research Fellow
      • 1987 - 1991

      Research on biochemistry, structure and calcium-regulated contraction of striated fibers and their major component, caltractin, in green algae

    • Postdoctoral Research Fellow
      • 1987 - 1991

      Research on molecular biology of photosynthetic oxygen evolution; research on biochemistry, structure and calcium-regulated contraction of striated fibers and their major component, caltractin, in green algae.

Education

  • Brown University
    Doctor of Philosophy (Ph.D.), Molecular and Cell Biology
  • University of Virginia
    Bachelor of Arts (B.A.), Biology

Community

You need to have a working account to view this content. Click here to join now